RegulatoryOfficial

Slovak regulator updates QRD Annex V after moving adverse reaction reporting form on its website

🇸🇰 ŠÚKL · Thu 19 Nov 2026

ŠÚKL has issued Version 36 of QRD Annex V to reflect the new website location of its suspected adverse drug reaction reporting form, with no regulatory action required.

The Slovak State Institute for Drug Control (ŠÚKL) has told marketing authorisation holders that QRD Annex V (EMA/67830/2013, Version 36) has been updated. The change follows the relocation of the form for reporting suspected adverse drug reactions on the ŠÚKL website. The notice was published on 19 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: ŠÚKL ↗

Article written by VigiEye from the official source (ŠÚKL). AI-assisted; check the source before acting.